{"title":"外科医生驱动的机器人肺叶切除术:在土耳其进行的第一例","authors":"C. Sezen, M. Metin","doi":"10.26663/cts.2022.008","DOIUrl":null,"url":null,"abstract":"In this case report, the case of non-small cell lung cancer resection performed with surgeon-powered robotic surgery (sPRS) was evaluated in light of the literature. A 62-year-old male patient applied to our clinic with the complaint of non-specific chest pain. On the tomography of the patient, a mass of approximately 1 cm in the lower lobe of the right lung was detected, and there was no distant metastasis. A transthoracic needle biopsy was performed on the patient. Right lower lobectomy operation was performed using wristed instruments (Artisential® Wristed Instruments) in this non-small cell lung cancer patient. sPRS provides more mobility than VATS and we think that it is a more cost effective surgical instrument than robotic surgery. We think that surgeons should embrace new technologies in order to provide more benefits to patients.","PeriodicalId":72729,"journal":{"name":"Current challenges in thoracic surgery","volume":"33 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Surgeon powered robotic lobectomy: first case performed in turkey\",\"authors\":\"C. Sezen, M. Metin\",\"doi\":\"10.26663/cts.2022.008\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"In this case report, the case of non-small cell lung cancer resection performed with surgeon-powered robotic surgery (sPRS) was evaluated in light of the literature. A 62-year-old male patient applied to our clinic with the complaint of non-specific chest pain. On the tomography of the patient, a mass of approximately 1 cm in the lower lobe of the right lung was detected, and there was no distant metastasis. A transthoracic needle biopsy was performed on the patient. Right lower lobectomy operation was performed using wristed instruments (Artisential® Wristed Instruments) in this non-small cell lung cancer patient. sPRS provides more mobility than VATS and we think that it is a more cost effective surgical instrument than robotic surgery. We think that surgeons should embrace new technologies in order to provide more benefits to patients.\",\"PeriodicalId\":72729,\"journal\":{\"name\":\"Current challenges in thoracic surgery\",\"volume\":\"33 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current challenges in thoracic surgery\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.26663/cts.2022.008\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current challenges in thoracic surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.26663/cts.2022.008","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Surgeon powered robotic lobectomy: first case performed in turkey
In this case report, the case of non-small cell lung cancer resection performed with surgeon-powered robotic surgery (sPRS) was evaluated in light of the literature. A 62-year-old male patient applied to our clinic with the complaint of non-specific chest pain. On the tomography of the patient, a mass of approximately 1 cm in the lower lobe of the right lung was detected, and there was no distant metastasis. A transthoracic needle biopsy was performed on the patient. Right lower lobectomy operation was performed using wristed instruments (Artisential® Wristed Instruments) in this non-small cell lung cancer patient. sPRS provides more mobility than VATS and we think that it is a more cost effective surgical instrument than robotic surgery. We think that surgeons should embrace new technologies in order to provide more benefits to patients.